viral target. New lab in India hopes to develop a vaccine against HIV ( above , to be released by infected cells).
National Institutes of Health
NEW DELHI -On Monday India opened a laboratory of $ 12 million government-backed, whose mission is to create a new vaccine against HIV. The Translational Research Laboratory vaccine against HIV, which aims to recruit about 30 scientists, is integrated within the Institute of Science and Technology of translational health facility of $ 0 million in development on the outskirts of New Delhi. It will work with the New York-based International AIDS Vaccine Initiative (IAVI); operating costs will be shared equally.
India has the third largest global burden of AIDS, despite the fact that "HIV infections have decreased by 56% during the last decade, from 270,000 in 00 to 0,000 in 09 "said Health Minister Ghulam Nabi Azad of India. He says there is a desperate need for a vaccine against HIV.
"The design of a new vaccine against HIV broad spectrum will be the mandate of this new laboratory," said Margaret G. McGlynn, CEO of IAVI. It can be done, she said: "Researchers have long known that, after several years of infection, a minority of people with HIV produce antibodies that can neutralize a broad range of HIV variants" The goal is to find. an antibody broad spectrum suitable for this purpose. McGlynn said the plan is to make and test a vaccine in India, she says is "properly placed with its scientific talented workforce, the well-established pharmaceutical industry and a huge commitment from the government. "
0 Komentar